Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation).

Conclusion. NACT in sinonasal tumours has a response rate of 80%. The protocol of NACT followed by local treatment is associated with improvement in outcomes as compared to our historical cohort. PMID: 26955484 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26955484?dopt=Abstract

Source: International Journal of Surgical Oncology - March 10, 2016 Category: Surgery Tags: Int J Surg Oncol Source Type: research